Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results
- Written by PR Newswire
SHENZHEN, China, Oct. 30, 2023 /PRNewswire/ -- Pulsecare Medical, an innovative minimally invasive and non-invasive therapeutic technology company, announced today that its nanosecond pulsed field ablation (nsPFA) system for cardiac electrophysiology, the world's first third-generation pulsed field ablation (PFA) system, has received satisfactory...














